Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Public ClinicalTrials.gov record NCT07478172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease
Study identification
- NCT ID
- NCT07478172
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Missouri-Columbia
- Other
- Enrollment
- 50 participants
Conditions and interventions
Conditions
- Amyotrophic Lateral Sclerosis
- Centronuclear Myopathy
- Charcot Marie Tooth Disease (CMT)
- Chronic Inflammatory Demyelinating Polyneuropathy
- Fascioscapulohumeral Muscular Dystrophy
- Hereditary Spastic Paraplegia
- Inclusion Body Myositis
- Lambert-eaton Myasthenic Syndrome
- Mitochondrial Myopathy
- Myasthenia Gravis
- Nemaline Myopathy
- Neuromuscular Diseases (NMD)
- Pompe Disease (Late-onset)
- Postpolio Syndrome
- Postural Orthostatic Tachycardia Syndrome (POTS)
- Primary Lateral Sclerosis
- Progressive Muscular Atrophy
- Spinal Muscular Atrophy
Interventions
- Whole-body Electrical Muscle Stimulation Exercise Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 9, 2026
- Primary completion
- Dec 30, 2030
- Completion
- Jan 6, 2031
- Last update posted
- Mar 16, 2026
2026 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NextGen Precision Health Building, Clinical and Translational Science Unit | Columbia | Missouri | 65211 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07478172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07478172 live on ClinicalTrials.gov.